Wuhan Changli BIOTECH Co., Ltd.
武汉市长立生物技术有限责任公司
Complete regulatory portfolio for Wuhan Changli BIOTECH Co., Ltd. in China's medical device market. This registrant has 141 medical devices registered with China NMPA, with registrations dating from Jul 10, 2019 to Jan 26, 2025.
Browse the complete device portfolio including device classifications, registration numbers, approval dates, and technical specifications. Pure Global AI provides free access to comprehensive China NMPA registration data, helping global MedTech companies analyze market presence and regulatory compliance for Chinese medical device manufacturers.
Free Database
Powered by Pure Global AI
NMPA Official Data
141 Devices
Company Overview
Total Devices
141
Province/Region
Hubei
湖北
Address
Room 01, 3rd floor, 4th floor, No. 388, Gaoxin 2nd Road, Wuhan Optics Valley International Biomedical Enterprise Accelerator, Phase 1.1, Phase 10, East Lake New Technology Development Zone, Wuhan
武汉市东湖新技术开发区高新二路388号武汉光谷国际生物医药企业加速器1.1期10栋3层01室、4层01室
Registration Timeline
Earliest Approval
Jul 10, 2019
Latest Approval
Jan 26, 2025
Device Class Distribution
Breakdown of 141 devices by regulatory classification
Class II
141
100.0% of total
Registered Devices (10 most recent shown)
Click on any device for detailed registration information